Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 22, Pages 5731-5736
Publisher
Proceedings of the National Academy of Sciences
Online
2017-05-16
DOI
10.1073/pnas.1700499114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nighttime Administration of Nicotine Improves Hepatic Glucose Metabolism via the Hypothalamic Orexin System in Mice
- (2016) Hiroshi Tsuneki et al. ENDOCRINOLOGY
- Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists
- (2015) Takashi Nagahara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Narcolepsy
- (2015) Thomas E. Scammell NEW ENGLAND JOURNAL OF MEDICINE
- International Classification of Sleep Disorders-Third Edition
- (2014) Michael J Sateia CHEST
- Hypothalamic Orexin Prevents Hepatic Insulin Resistance via Daily Bidirectional Regulation of Autonomic Nervous System in Mice
- (2014) Hiroshi Tsuneki et al. DIABETES
- Orexin neurons suppress narcolepsy via 2 distinct efferent pathways
- (2014) Emi Hasegawa et al. JOURNAL OF CLINICAL INVESTIGATION
- GABAB Agonism Promotes Sleep and Reduces Cataplexy in Murine Narcolepsy
- (2014) S. W. Black et al. JOURNAL OF NEUROSCIENCE
- Conditional Ablation of Orexin/Hypocretin Neurons: A New Mouse Model for the Study of Narcolepsy and Orexin System Function
- (2014) S. Tabuchi et al. JOURNAL OF NEUROSCIENCE
- Role of the Medial Prefrontal Cortex in Cataplexy
- (2013) Y. Oishi et al. JOURNAL OF NEUROSCIENCE
- Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
- (2013) J. M. Uslaner et al. Science Translational Medicine
- How do the basal ganglia regulate sleep–wake behavior?
- (2012) Michael Lazarus et al. TRENDS IN NEUROSCIENCES
- Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice
- (2011) T. Mochizuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
- (2010) Christopher D. Cox et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX2 receptor
- (2009) P Malherbe et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hypothalamic Orexin Stimulates Feeding-Associated Glucose Utilization in Skeletal Muscle via Sympathetic Nervous System
- (2009) Tetsuya Shiuchi et al. Cell Metabolism
- Enhanced Orexin Receptor-2 Signaling Prevents Diet-Induced Obesity and Improves Leptin Sensitivity
- (2009) Hiromasa Funato et al. Cell Metabolism
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search